We are live on ! Find out more
DLA

Douglas Lane & Associates Portfolio holdings

AUM $7.37B
1-Year Est. Return 21.9%
This Fund
S&P 500
This Quarter Est. Return
+10.43%
1 Year Est. Return
+21.9%
3 Year Est. Return
+71.89%
5 Year Est. Return
+87.03%
10 Year Est. Return
+444.88%
AUM
$5.38B
AUM Growth
+$356M
Cap. Flow
-$95.3M
Cap. Flow %
-1.77%
Top 10 Hldgs %
22.08%
Holding
225
New
6
Increased
74
Reduced
113
Closed
13

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$41.5M
2
SLB icon
SLB Ltd
SLB
+$19.4M
3
GSK icon
GSK
GSK
+$15.1M
4
EOG icon
EOG Resources
EOG
+$10.5M
5
APA icon
APA Corp
APA
+$9M

Top Sells

Rank Stock Value
1
PPLI
People Inc
PPLI
+$80.1M
2
CELG
Celgene Corp
CELG
+$72.6M
3
BWA icon
BorgWarner
BWA
+$26.4M
4
EXPE icon
Expedia Group
EXPE
+$26.1M
5
XRAY icon
Dentsply Sirona
XRAY
+$19.3M

Sector Composition

Rank Sector Weight
1 Financials 23.04%
2 Technology 14.53%
3 Industrials 13.46%
4 Healthcare 13.02%
5 Consumer Discretionary 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVX icon
76
Chevron
CVX
$366B
$22.1M 0.41%
183,775
+40,060
+28% +$4.72M
ULTA icon
77
Ulta Beauty
ULTA
$23.7B
$20.8M 0.39%
82,295
+24,311
+42% +$5.94M
VRSK icon
78
Verisk Analytics
VRSK
$25.1B
$20.7M 0.38%
138,548
-16,714
-11% -$2.48M
AAPL icon
79
Apple
AAPL
$4.58T
$20.5M 0.38%
278,816
-7,224
-3% -$465K
SSYS icon
80
Stratasys
SSYS
$770M
$20.3M 0.38%
1,001,815
+141,805
+16% +$2.82M
ITW icon
81
Illinois Tool Works
ITW
$85.2B
$20M 0.37%
111,312
-1,911
-2% -$324K
PEP icon
82
PepsiCo
PEP
$189B
$19.1M 0.36%
140,116
-2,063
-1% -$281K
KO icon
83
Coca-Cola
KO
$374B
$19M 0.35%
343,325
+1,279
+0.4% +$68.8K
YELP icon
84
Yelp
YELP
$1.53B
$18.5M 0.34%
532,497
-173,575
-25% -$5.89M
XRAY icon
85
Dentsply Sirona
XRAY
$2.43B
$17.5M 0.33%
309,541
-346,267
-53% -$19.3M
GIS icon
86
General Mills
GIS
$19.4B
$17.2M 0.32%
321,156
+27,342
+9% +$1.44M
SCHW
87
Charles Schwab
SCHW
$186B
$17M 0.32%
357,006
-80,808
-18% -$3.56M
INTC icon
88
Intel
INTC
$503B
$14.9M 0.28%
249,740
-19,647
-7% -$1.1M
ACN icon
89
Accenture
ACN
$106B
$14.6M 0.27%
69,419
-4,982
-7% -$971K
EXPD icon
90
Expeditors International
EXPD
$23.4B
$14M 0.26%
178,969
-1,215
-0.7% -$91K
EL icon
91
Estee Lauder
EL
$31.6B
$13.8M 0.26%
66,642
-1,745
-3% -$339K
CMCSA icon
92
Comcast
CMCSA
$89.9B
$13.6M 0.25%
302,200
-5,944
-2% -$265K
PPLI
93
People Inc
PPLI
$3.19B
$13.1M 0.24%
293,860
-1,987,824
-87% -$80.1M
AMGN icon
94
Amgen
AMGN
$219B
$11.9M 0.22%
49,424
-2,318
-4% -$511K
ZION icon
95
Zions Bancorporation
ZION
$10.3B
$10.3M 0.19%
199,042
-14,365
-7% -$697K
CLB icon
96
Core Laboratories
CLB
$519M
$10.2M 0.19%
270,553
+100,081
+59% +$4.5M
CB icon
97
Chubb
CB
$136B
$9.89M 0.18%
63,542
+19,298
+44% +$2.95M
VMC icon
98
Vulcan Materials
VMC
$36.9B
$9.76M 0.18%
67,784
-738
-1% -$106K
JNJ icon
99
Johnson & Johnson
JNJ
$618B
$9.57M 0.18%
65,622
+1,117
+2% +$152K
AAL icon
100
American Airlines Group
AAL
$10.5B
$9.52M 0.18%
332,078
+6,037
+2% +$172K
2 3
4
5 6

Similar funds

BIM
Bridges Investment Management Omaha, Nebraska $7.38B AUM 15.39% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
KWM
Kingsview Wealth Management Grants Pass, Oregon $7.33B AUM 16.07% 1-Year Est. Return
GLF
Groupe la Francaise Paris, France $7.29B AUM 37.28% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
YAM
Yacktman Asset Management Austin, Texas $7.5B AUM 22.48% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Douglas Lane & Associates's Q4 2019 Portfolio in Review

As of Q4 2019, Douglas Lane & Associates held 225 positions worth $5.38B, up 7.1% from $5.02B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Douglas Lane & Associates's Q4 2019 filing shows 6 new, 74 increased, 113 reduced and 13 closed positions. Its largest new stake was Elanco Animal Health: 120,472 shares worth $3.55M. The largest sale was People Inc, an estimated $80.1M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.

  • Douglas Lane & Associates's largest Q4 2019 buy was Elanco Animal Health: 120,472 shares worth $3.55M.
  • Douglas Lane & Associates added most to Bristol-Myers Squibb in Q4 2019, an estimated $41.5M increase.
  • Douglas Lane & Associates's biggest Q4 2019 reduction was People Inc, cutting an estimated $80.1M.
  • Douglas Lane & Associates fully exited Celgene Corp in Q4 2019, selling an estimated $72.6M.
  • Douglas Lane & Associates's ten largest holdings make up 22% of its $5.38B portfolio in Q4 2019.
  • Douglas Lane & Associates opened 6 new positions and closed 13 in Q4 2019.
  • Douglas Lane & Associates's portfolio value rose 7.1% quarter-over-quarter to $5.38B.

Based on Douglas Lane & Associates's 13F filing for Q4 2019, filed 27 Jan 2020.